Clinical Trials
8 trialsNCT07025005 2025-11-04
VRd MM Fibrate
Tanta University
Phase 4 Recruiting
NCT06191133 2025-10-02
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
Case Comprehensive Cancer Center
Phase 1 Recruiting
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT05813145 2025-07-08
Fenofibrate Role in Breast Cancer Patients
Damanhour University
Phase NA Completed
NCT01574131 2019-11-29
Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients
The University of Texas Medical Branch, Galveston
Phase 4 Terminated
NCT01965834 2017-06-14
Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
University of Miami
Phase 2 Terminated
NCT00884819 2015-04-03
Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Terminated
NCT00357500 2014-10-01
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer
Dana-Farber Cancer Institute
Phase 2 Completed